Literature DB >> 29268442

The role and potential mechanisms of long non-coding RNA in small cell lung cancer.

Yuchun Niu1, Feng Ma1, Jun Xue2, Weimei Huang3, Linlang Guo3.   

Abstract

Entities:  

Year:  2017        PMID： 29268442      PMCID： PMC5723897          DOI： 10.21037/jtd.2017.09.70

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  10 in total

1.  MALAT1 induces tongue cancer cells' EMT and inhibits apoptosis through Wnt/β-catenin signaling pathway.

Authors:  Jun Liang; Lizhong Liang; Kexiong Ouyang; Zhiqiang Li; Xianping Yi
Journal:  J Oral Pathol Med       Date:  2016-06-29       Impact factor: 4.253

2.  Long non-coding RNA TUG1: a novel therapeutic target in small cell lung cancer.

Authors:  Chunlin Ou; Guiyuan Li
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

Review 3.  Long Noncoding RNA and Cancer: A New Paradigm.

Authors:  Arunoday Bhan; Milad Soleimani; Subhrangsu S Mandal
Journal:  Cancer Res       Date:  2017-07-12       Impact factor: 12.701

4.  LncRNA, TUG1 regulates the oral squamous cell carcinoma progression possibly via interacting with Wnt/β-catenin signaling.

Authors:  Shuang Liang; Songzi Zhang; Peng Wang; Chao Yang; Chen Shang; Jianjun Yang; Jun Wang
Journal:  Gene       Date:  2017-01-22       Impact factor: 3.688

5.  CEBPA-mediated upregulation of the lncRNA PLIN2 promotes the development of chronic myelogenous leukemia via the GSK3 and Wnt/β-catenin signaling pathways.

Authors:  Chengming Sun; Shuping Luan; Guili Zhang; Na Wang; Huiyuan Shao; Caifu Luan
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

6.  Cancer statistics, 2013.

Authors:  Rebecca Siegel; Deepa Naishadham; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2013-01-17       Impact factor: 508.702

7.  Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression.

Authors:  Ahmad M Khalil; Mitchell Guttman; Maite Huarte; Manuel Garber; Arjun Raj; Dianali Rivea Morales; Kelly Thomas; Aviva Presser; Bradley E Bernstein; Alexander van Oudenaarden; Aviv Regev; Eric S Lander; John L Rinn
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-01       Impact factor: 11.205

8.  The long non-coding RNA HOTTIP promotes progression and gemcitabine resistance by regulating HOXA13 in pancreatic cancer.

Authors:  Zhihua Li; Xiaohui Zhao; Yu Zhou; Yimin Liu; Quanbo Zhou; Huilin Ye; YinXue Wang; Jinlong Zeng; Yadong Song; Wenchao Gao; ShangYou Zheng; Baoxiong Zhuang; Huimou Chen; Wenzhu Li; Haigang Li; Haifeng Li; Zhiqiang Fu; Rufu Chen
Journal:  J Transl Med       Date:  2015-03-12       Impact factor: 5.531

9.  Over-expressed long noncoding RNA HOXA11-AS promotes cell cycle progression and metastasis in gastric cancer.

Authors:  Zhili Liu; Zhenyao Chen; Ruihua Fan; Bin Jiang; Xin Chen; Qinnan Chen; Fengqi Nie; Kaihua Lu; Ming Sun
Journal:  Mol Cancer       Date:  2017-04-26       Impact factor: 27.401

10.  Long non-coding RNA TUG1 promotes endometrial cancer development via inhibiting miR-299 and miR-34a-5p.

Authors:  Lifen Liu; Xin Chen; Ying Zhang; Yanrong Hu; Xiaoqing Shen; Weipei Zhu
Journal:  Oncotarget       Date:  2017-05-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.